Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
UROLOGY / SYSTEMATIC REVIEW/META-ANALYSIS
Erectile dysfunction in testicular cancer survivors: a meta-analysis of case-control studies
1
Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, China
Submission date: 2019-09-05
Final revision date: 2019-12-03
Acceptance date: 2019-12-24
Online publication date: 2020-01-15
Arch Med Sci 2024;20(3):822-830
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Testicular cancer (TC) is the most frequent cancer among men aged 14–44 years. The risk of erectile dysfunction (ED) in TC patients varied within a wide range across different studies. This study aims to estimate the risk of ED in TC patients by conducting a meta-analysis of case-control studies.
Material and methods:
Relevant studies were searched using PubMed, EMBASE, Scopus, and the Cochrane Library up to June 2019. Case-control studies that reported the incidence of ED in TC patients were included.
Results:
A total of 8 studies involving 2060 TC patients and 2651 healthy men were included. All the TC patients underwent unilateral orchiectomy; other treatment modalities were also conducted if necessary. ED occurred in 16.9% (348/2060) of TC patients and 9.4% (251/2651) of healthy men. Compared with healthy men, TC patients experienced a significantly increased risk of ED (OR = 2.39, 95% CI: 1.56–3.67). Substantial heterogeneity was observed. In addition, subgroup analysis revealed that the risk (OR = 3.76, 95% CI: 2.45–5.78) for ED in TC patients with follow-up < 5 years was significantly higher than that (OR = 1.61, 95% CI: 1.10–3.67) with follow-up ≥ 5 years. Heterogeneity was improved after subgroup analysis.
Conclusions:
TC patients experienced an increased risk for ED compared with healthy men. The long-term risk for ED in TC patients was lower than the short-term risk.
Testicular cancer (TC) is the most frequent cancer among men aged 14–44 years. The risk of erectile dysfunction (ED) in TC patients varied within a wide range across different studies. This study aims to estimate the risk of ED in TC patients by conducting a meta-analysis of case-control studies.
Material and methods:
Relevant studies were searched using PubMed, EMBASE, Scopus, and the Cochrane Library up to June 2019. Case-control studies that reported the incidence of ED in TC patients were included.
Results:
A total of 8 studies involving 2060 TC patients and 2651 healthy men were included. All the TC patients underwent unilateral orchiectomy; other treatment modalities were also conducted if necessary. ED occurred in 16.9% (348/2060) of TC patients and 9.4% (251/2651) of healthy men. Compared with healthy men, TC patients experienced a significantly increased risk of ED (OR = 2.39, 95% CI: 1.56–3.67). Substantial heterogeneity was observed. In addition, subgroup analysis revealed that the risk (OR = 3.76, 95% CI: 2.45–5.78) for ED in TC patients with follow-up < 5 years was significantly higher than that (OR = 1.61, 95% CI: 1.10–3.67) with follow-up ≥ 5 years. Heterogeneity was improved after subgroup analysis.
Conclusions:
TC patients experienced an increased risk for ED compared with healthy men. The long-term risk for ED in TC patients was lower than the short-term risk.
REFERENCES (29)
1.
Aparicio J, Terrasa J, Durán I, et al. SEOM clinical guidelines for the management of germ cell testicular cancer. Clin Transl Oncol 2016; 18: 1187-96.
2.
Vignera SL, Cannarella R, Duca Y, et al. Hypogonadism and sexual dysfunction in testicular tumor survivors: a systematic review. Front Endocrinol 2019; 10: 264.
3.
Capocaccia R, Gatta G, Dal ML, et al. Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data. Ann Oncol 2015; 26: 1263-8.
4.
Rieker PP, Fitzgerald EM, Kalish LA, et al. Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer 1989; 64: 2399-407.
5.
Fung C, Sesso HD, Williams AM, et al. Multi-institutional assessment of adverse health outcomes among north american testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol 2017; 35: JCO2016703108.
6.
Wortel RC, Alemayehu WG, Luca Incrocci MD, et al. Orchiectomy and radiotherapy for stage I-II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function. J Sex Med 2015; 12: 210-8.
7.
Pühse G, Wachsmuth JU, Kemper S, et al. Chronic pain has a negative impact on sexuality in testis cancer survivors. J Androl 2012; 33: 886-93.
8.
Catanzariti F, Polito B, Polito M, et al. Testicular prosthesis: patient satisfaction and sexual dysfunctions in testis cancer survivors. Arch Ital Urol Androl 2016; 13: S232-S.
9.
Raanan T, Stember DS, Nina L, et al. Erectile dysfunction in men treated for testicular cancer. BJU Int 2014; 113: 907-10.
10.
Jonker-Pool G, Wiel HBMVD, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer – review and meta-analysis of 36 empirical studies between 1975–2000. Arch Sex Behav 2001; 30: 55-74.
11.
Douchez J, Droz JP, Desclaux B, et al. Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. J Urol 1993; 149: 498-501.
12.
Tinkler SD, Howard GC, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol 1992; 25: 207-12.
13.
Pallotti F, Petrozzi A, Cargnelutti F, et al. Long-term follow up of the erectile function of testicular cancer survivors. Front Endocrinol 2019; 10: 196.
14.
Eberhard J, Ståhl O, Cohn-Cedermark G, et al. Sexual function in men treated for testicular cancer. J Sex Med 2010; 6: 1979-89.
15.
Kim C, Mcglynn KA, Mccorkle R, et al. Sexual functioning among testicular cancer survivors: a case-control study in the U.S. J Psychosom Res 2012; 73: 68-73.
16.
Schover LR, von Eschenbach AC. Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 1985; 25: 251-5.
17.
Joly F, Héron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 2001; 20: 73-80.
18.
Dahl AA, Bremnes R, Dahl O, et al. Is the sexual function compromised in long-term testicular cancer survivors? Eur Urol 2007; 52: 1438-47.
19.
Alacacioglu A, Ulger E, Varol U, et al. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol 2014; 31: 43.
20.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
21.
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/cl....
22.
Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
23.
Blackmore C. The impact of orchidectomy upon the sexuality of the man with testicular cancer. Cancer Nurs 1988; 11: 33-40.
24.
Tasdemir C, Firdolas F, Harputluoglu H, et al. Erectile dysfunction in testicular cancer patients treated with chemotherapy. Andrologia 2012; 44: 226-9.
25.
Bloom JR, Fobair P, Gritz E, et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 1993; 11: 979-88.
26.
Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review J Psychosom Res 2001; 51: 735-43.
27.
Rossen P, Pedersen AF, Zachariae R, et al. Sexuality and body image in long-term survivors of testicular cancer. Eur J Cancer 2012; 48: 571-8.
28.
Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol 2005; 23: 2389-95.
29.
Susanne R, Ellids K, Giraldi AGE. Sexual dysfunctions in men treated for testicular cancer--secondary publication. Danish Med Bull 2008; 55: 211-5.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
